Hurxley 

¥710
5
-¥3-0.42% 06:16 Today

Statistics

Day High
715
Day Low
708
52W High
819
52W Low
611
Volume
8,100
Avg. Volume
17,106
Mkt Cap
13.53B
P/E Ratio
9.27
Dividend Yield
2.1%
Dividend
14.94

Upcoming

Dividends

2.1%Dividend Yield
Jun 26
¥14
Dec 25
¥14
Jun 25
¥13
Dec 24
¥13
Jun 24
¥15
10Y Growth
2.21%
5Y Growth
47.58%
3Y Growth
15.87%
1Y Growth
7.69%

Earnings

18NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-2.38
11.23
24.85
38.47
Expected EPS
N/A
Actual EPS
N/A

Financials

2.67%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
45.18BRevenue
1.2BNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Eisai
4523.TSE
Mkt Cap1.69T
Eisai Co., Ltd. operates in the same pharmaceutical sector, focusing on neurology and oncology, which overlaps with Hurxley's therapeutic areas.
Takeda Pharmaceutical
4502.TSE
Mkt Cap6.05T
Takeda Pharmaceutical Company Limited offers a broad range of pharmaceutical products that directly compete across several of Hurxley's key markets.
Astellas Pharma
4503.TSE
Mkt Cap3.68T
Astellas Pharma Inc. is involved in the development of pharmaceuticals in areas similar to Hurxley, making it a direct competitor in those therapeutic fields.
Shionogi &.
4507.TSE
Mkt Cap2.12T
Shionogi & Co., Ltd. focuses on the development of pharmaceuticals for infectious diseases and pain, which competes with some of Hurxley's product lines.
Chugai Pharmaceutical
4519.TSE
Mkt Cap6.03T
Chugai Pharmaceutical Co., Ltd. specializes in biopharmaceuticals, competing with Hurxley in the biotech and pharmaceutical sectors.
Kyowa Kirin.
4151.TSE
Mkt Cap1.75T
Kyowa Kirin Co., Ltd. targets similar markets in pharmaceuticals, particularly in nephrology and immunology, areas where Hurxley is also active.
Daiichi Sankyo.
4568.TSE
Mkt Cap8.21T
Daiichi Sankyo Company, Limited manufactures medicines in oncology, a key area for Hurxley, thus posing significant competition.
OtsukaLtd.
4578.TSE
Mkt Cap2.43T
Otsuka Holdings Co., Ltd. offers a diverse portfolio in pharmaceuticals, including neurological drugs, directly competing with Hurxley's products.
Ono Pharmaceutical
4528.TSE
Mkt Cap1.65T
Ono Pharmaceutical Co., Ltd. produces drugs for an array of diseases, including those treated by Hurxley's products, making it a competitor.
Tsumura
4540.TSE
Mkt Cap239.85B
Nichi-Iko Pharmaceutical Co., Ltd. is a generic and specialty pharmaceutical company that competes in the broader pharmaceutical market alongside Hurxley.

About

Hurxley Holdings Corporation, together with its subsidiaries, operates Hokka Hokka Tei franchise chain stores in Japan. The company offers boxed lunches. It is also involved in storage and distribution of foodstuffs at franchisees and directly managed stores; rice milling and processing of BG rice; and processing of foodstuff. In addition, the company provides store leasing for restaurant operators; management and investment services; and system development, business, design work, and portal site management services. Further, it engages in the preparation and manufacture of japanese, western, chinese, sushi, and confectionery; provision of catering, and venue coordination and installation services; rental of party tableware and accessories; wholesale of tableware and kitchen equipment, as well as fruit, dry fruit, squid dried foods, dried seafood products, salamis, and beef tansmoks; sale of dried fruit and other related products; development and production of cooked foods made mainly from meat; and manufacture and sale of peanuts, nuts, and bean confectioner. Additionally, the company also engages in store asset and solutions business, focuses on acquisition, development, leasing, and management of commercial real estate; production and sales of leafy vegetables such as lettuce in artificial light-based automated plant factories; and logistics and food processing business. The company was formerly known as Hurxley Corporation and changed its name to Hurxley Holdings Corporation in July 2026. Hurxley Holdings Corporation was founded in 1976 and is headquartered in Kita, Japan.
Show more...
CEO
Tatsuya Aoki
Employees
753
Country
Japan
ISIN
JP3765100007

Listings

0 Comments

Share your thoughts

FAQ

What is Hurxley stock price today?
The current price of 7561.TSE is ¥710 JPY — it has decreased by -0.42% in the past 24 hours. Watch Hurxley stock price performance more closely on the chart.
What is Hurxley stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Tokyo Stock Exchange exchange Hurxley stocks are traded under the ticker 7561.TSE.
Is Hurxley stock price growing?
7561.TSE stock has fallen by -2.2% compared to the previous week, the month change is a +1.57% rise, over the last year Hurxley has showed a +9.91% increase.
What is Hurxley market cap?
Today Hurxley has the market capitalization of 13.53B
When is the next Hurxley earnings date?
Hurxley is going to release the next earnings report on November 18, 2026.
What were Hurxley earnings last quarter?
7561.TSE earnings for the last quarter are 34.31 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Hurxley revenue for the last year?
Hurxley revenue for the last year amounts to 45.18B JPY.
What is Hurxley net income for the last year?
7561.TSE net income for the last year is 1.2B JPY.
Does Hurxley pay dividends?
Yes, 7561.TSE dividends are paid semi-annual. The last dividend per share was 14 JPY. As of today, Dividend Yield (FWD)% is 2.1%.
How many employees does Hurxley have?
As of September 08, 2026, the company has 753 employees.
In which sector is Hurxley located?
Hurxley operates in the Lifestyle & Brands sector.
When did Hurxley complete a stock split?
The last stock split for Hurxley was on September 29, 2021 with a ratio of 2:1.
Where is Hurxley headquartered?
Hurxley is headquartered in Kita, Japan.